US Edition
Breckenridge Pharmaceutical announces FDA approval for Dehydrated Alcohol Injection USP
Summary by ROI-NJ
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Breckenridge Pharmaceutical announces FDA approval for Dehydrated Alcohol Injection USP
Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International based in Berkeley Heights that markets, distributes and sells generic medicines in the U.S., announced that the Food and Drug Administration (FDA) has approved its Dehydrated Alcohol Injection, USP, 5 mL of ≥ 99% by volume ethyl alcohol single-dose vials, a generic version of Ablysinol® by Belcher Pharmaceuticals, LLC, developed in partnership with Andersen Pharma Globa…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
